Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
21 mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
55 mg Montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬
[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 98 💬
6[BUL 0.5 mg]----[1] 98 💬
7[BUL 1 mg]----[1] 98 💬
8[CC-93538]----[1] 98 💬
9[CDX-0159]----[1] 98 💬
10[MEDI-563]----[5] 44, 45, 98, 162, 299 💬
11[MEDI9929 anti-TSLP mAb (AMG157)][1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
12[NA]----[34] 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
13AK002----[1] 98 💬
14Allergy immunotherapy (allergy shots)----[1] 98 💬
15Alpha-proteinase inhibitor----[1] 98 💬
16AMG 157[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
17AMG157----[1] 98 💬
18APD334----[5] 93, 96, 97, 98, 269 💬
19APT-1011----[1] 98 💬
20APT-1011 - 3 mg----[1] 98 💬
21APT-1011 3 mg HS----[1] 98 💬
22AQ280----[1] 98 💬
23AQ280 Capsule----[1] 98 💬
24AQ280 Tablet for Oral Suspension----[1] 98 💬
25AR401959 L-arginine[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬
--[3] 96, 97, 98 💬
26Arginine[1] Arginine[3] Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬
--[16] 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
27Baked Milk----[1] 98 💬
28Barium[1] Barium---[5] 2, 6, 19, 97, 98 💬
29Barzolvolimab[1] Barzolvolimab[1] Barzolvolimab 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 98 💬
30Beclomethasone dipropionate[1] Beclomethasone dipropionate[3] Beclomethasone dipropionate ,
Beclometasone ,
Beclomethasone dipropionate monohydrate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 98 💬
31Behavioral: six-foods elimination diet----[1] 98 💬
32Benralizumab[1] Benralizumab[1] Benralizumab 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬
33Bethanechol[1] Bethanechol[1] Bethanechol chloride 💬 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 98 💬
34Blood sampling----[15] 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
35BT-11 high----[1] 98 💬
36BT-11 low----[1] 98 💬
37BUDESONIDE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[10] 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
38Budesonide 0.5 mg compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
39Budesonide 0.5 mg orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
40Budesonide 0.5mg orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
41Budesonide 1 mg compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42Budesonide 1 mg orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
43Budesonide 1 mg orodispersible tablets (BUL 1 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
44Budesonide 1mg orodispersible tablet twice daily[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
45Budesonide 2 mg orodispersible tablets (BUL 2 mg)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
46Budesonide [0.4mg/ml] viscous suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
47Budesonide Gel[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
48Budesonide oral suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
49Budesonide oral suspension [0.2 mg/ml][1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
50Budesonide Orodispersible Tablets (Jorveza)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
51Budesonide plus Prevacid[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
52BUET 0.5 mg----[1] 98 💬
53BUET 1 mg----[1] 98 💬
54BUET 1mg----[1] 98 💬
55BUET 2mg----[1] 98 💬
56BUL 0.5 mg----[1] 98 💬
57BUL 1 mg----[1] 98 💬
58BUU 0.4mg/ml----[1] 98 💬
59CALY-002[1] CALY-002---[1] 98 💬
60CC-93538----[1] 98 💬
61CDX-0159----[1] 98 💬
62Cendakimab[1] Cendakimab[1] Cendakimab 💬 [1] IL13 💬 [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬[1] 98 💬
63Citalopram[1] Citalopram[2] Citalopram hydrobromide ,
Citalopram 💬
[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[7] 6, 8, 13, 18, 46, 98, 127 💬
64Compressa effervescente 0,5 mg di budesonide per uso orodispersibile[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
65Compressa effervescente 1 mg di budesonide per uso orodispersibile[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
66CYP substrates----[1] 98 💬
67Dexlansoprazole[1] Dexlansoprazole[2] Dexlansoprazole ,
Dexlansoprazole sesquihydrate 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
68Diagnostic Test: Barium Esophagram[1] Barium---[1] 98 💬
69Diagnostic Test: Bone Mineral Density (DEXA) scan----[1] 98 💬
70Diagnostic Test: Cortisol level----[1] 98 💬
71Diagnostic Test: Endoscopy while on study drug----[1] 98 💬
72Diagnostic Test: esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal----[1] 98 💬
73Diagnostic Test: Gastrointestinal Quality of Life index----[1] 98 💬
74Diagnostic Test: Height measurement----[1] 98 💬
75Diagnostic Test: High-resolution manometry----[1] 98 💬
76Diagnostic Test: Physical Examination and Questionnaires----[1] 98 💬
77Diagnostic Test: Retrospective evaluation of endoscopy prior to study drug----[1] 98 💬
78Diagnostic Test: Serum biomarkers----[1] 98 💬
79Diagnostic Test: SPECT/CT Imaging----[1] 98 💬
80Diagnostic Test: Vitamin D Measurement[1] Vitamin D---[1] 98 💬
81Dose----[1] 98 💬
82Dupilumab[1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[8] 51, 97, 98, 160, 162, 222, 300, 306 💬
83Dupilumab (blinded)[1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 98 💬
84Dupilumab (open-label)[1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 98 💬
85Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT][1] Dupilumab[1] Dupilumab 💬 [1] IL4R 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 98 💬
86Dupixent----[3] 98, 160, 162 💬
87Else nutrition formula----[1] 98 💬
88Eosinophilic Esophagitis (E0E) food introduction-2nd----[1] 98 💬
89Eosinophilic Esophagitis (EoE) food introduction-1st----[1] 98 💬
90Eosinophilic Esophagitis (EoE) Food introduction-3rd dose----[1] 98 💬
91EP-104GI----[1] 98 💬
92ESO-101----[1] 98 💬
93Esomeprazole[1] Esomeprazole[5] Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[10] 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
94EsophaCap----[1] 98 💬
95Esophageal biopsies----[1] 98 💬
96Esophageal dilation----[1] 98 💬
97Esophagogastroduodenoscopy----[1] 98 💬
98Etrasimod[1] Etrasimod[2] Etrasimod ,
Etrasimod arginine 💬
[3] S1PR1,
S1PR4,
S1PR5 💬
[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 96, 97, 98 💬
99Etrasimod L-arginine[3] Arginine,
Etrasimod,
L-arginine
[5] Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
[3] S1PR1,
S1PR4,
S1PR5 💬
[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 96, 97, 98 💬
100EUR-1100----[1] 98 💬
101Famotidine[1] Famotidine[1] Famotidine 💬 [1] HRH2 💬 [4] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[7] 6, 46, 86, 98, 107, 145, 300 💬
102Fasenra----[5] 44, 45, 98, 162, 299 💬
103Florence 30 µg/mL----[1] 98 💬
104Florence 60 µg/mL----[1] 98 💬
105Florence 90 µg/mL----[1] 98 💬
106Flovent----[1] 98 💬
107Fluticasone[1] Fluticasone[1] Fluticasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[4] 98, 228, 299, 306 💬
108Fluticasone MDI[1] Fluticasone[1] Fluticasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
109FLUTICASONE PROPIONATE[2] Fluticasone,
Fluticasone propionate
[2] Fluticasone propionate ,
Fluticasone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 98, 228, 306 💬
110Fluticasone Propionate, 800 mcg twice daily (post 4FED failure)[2] Fluticasone,
Fluticasone propionate
[2] Fluticasone propionate ,
Fluticasone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
111Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)[2] Fluticasone,
Fluticasone propionate
[2] Fluticasone propionate ,
Fluticasone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
112Fluticasone Propionate, USP[2] Fluticasone,
Fluticasone propionate
[2] Fluticasone propionate ,
Fluticasone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
113Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
114High dose budesonide suspension[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
115High dose budesonide tablet[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
116Honey[1] Honey[1] Honey 💬 --[4] 57, 63, 98, 230 💬
117Humanised IgG1k monoclonal antibody against KIT----[1] 98 💬
118Infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
119Inhaled/swallowed budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
120Intraluminal Impedance----[1] 98 💬
121Intubated with Propofol (IP)[1] Propofol[1] Propofol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 98 💬
122Intubated with Sevoflurane (IS)[1] Sevoflurane[1] Sevoflurane 💬 --[1] 98 💬
123IRL201104----[1] 98 💬
124Jorveza----[1] 98 💬
125Jorveza 0.5 mg compresse orodispersibili----[1] 98 💬
126Jorveza 0.5 mg orodispersible tablets----[1] 98 💬
127Jorveza 1 mg compresse orodispersibili----[1] 98 💬
128Jorveza 1 mg orodispersible tablets----[1] 98 💬
129L-arginine[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬
--[10] 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
130Lansoprazole[1] Lansoprazole[1] Lansoprazole 💬 [2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[8] 63, 71, 85, 98, 166, 222, 223, 299 💬
131Lirentelimab[1] Lirentelimab[1] Lirentelimab 💬 --[1] 98 💬
132Lirentelimab (AK002)[1] Lirentelimab[1] Lirentelimab 💬 --[1] 98 💬
133Loratadine[1] Loratadine[1] Loratadine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 13, 19, 46, 89, 98 💬
134Losartan[1] Losartan[2] Losartan potassium ,
Losartan 💬
[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[20] 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
135LOSARTAN POTASSIUM[2] Losartan,
Potassium
[3] Losartan potassium ,
Losartan ,
Potassium 💬
[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[5] 36, 98, 167, 179, 215 💬
136Low dose budesonide tablet[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
137MEDI-563----[5] 44, 45, 98, 162, 299 💬
138MEDI9929 anti-TSLP mAb (AMG157)[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
139MEPOLIZUMAB[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[4] 44, 45, 98, 162 💬
140Mepolizumab 100 mg[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 98 💬
141Mepolizumab 300 mg[1] Mepolizumab[1] Mepolizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[3] 44, 45, 98 💬
142Mesalamine Oral Product----[1] 98 💬
143Mometasone[1] Mometasone[1] Mometasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 98, 162 💬
144MOMETASONE FUROATE[2] Mometasone,
Mometasone furoate
[3] Mometasone furoate ,
Mometasone furoate hydrate ,
Mometasone 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 98, 162 💬
145Montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬
[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[10] 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
146Montelukast/ Singulair[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬
[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 98 💬
147Nasonex----[1] 98 💬
148NDX-3315[1] NDX-3315---[1] 98 💬
149NDX-3324----[1] 98 💬
150NIOX MINO® Airway Inflammation Monitor----[1] 98 💬
151Nitric Oxide[1] Nitric Oxide[1] Nitric oxide 💬 --[12] 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
152OC000459----[1] 98 💬
153OMALIZUMAB[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[7] 46, 53, 65, 98, 162, 226, 299 💬
154Omeprazole[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[18] 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
155Omeprazole 20 MG Oral Tablet[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
156Omeprazole 20mg BID[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
157Ondansetron[1] Ondansetron[2] Ondansetron ,
Ondansetron hydrochloride hydrate 💬
[5] HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬
[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 97, 98, 107, 231 💬
158Oral Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 98 💬
159Oral Budesonide Suspension (MB-9)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
160Oral Budesonide Suspension (OBS)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
161Oral cromolyn sodium----[1] 98 💬
162Oral Viscous Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
163Oral Viscous Budesonide (OVB)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
164Other: 1 Food Elimination Diet----[1] 98 💬
165Other: 1 Food Elimination Diet Therapy----[1] 98 💬
166Other: 4 Food Elimination Diet----[1] 98 💬
167Other: 4 Food Elimination Diet (post 1FED failure)----[1] 98 💬
168Other: 6 Food Elimination Diet (after 1FED failure)----[1] 98 💬
169Other: 6 Food Elimination Diet Therapy----[1] 98 💬
170Other: Antigen (wheat base soy sauce) spray[1] Wheat[1] Wheat 💬 --[1] 98 💬
171Other: Assessment of medication compliance----[1] 98 💬
172Other: Biopsy samples----[1] 98 💬
173Other: Blood Samples----[13] 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
174Other: D-xylose[1] Xylose[1] Xylose 💬 --[1] 98 💬
175Other: Elimination diet----[1] 98 💬
176Other: Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis----[1] 98 💬
177Other: Honey[1] Honey[1] Honey 💬 --[1] 98 💬
178Other: Matching vehicle control----[1] 98 💬
179Other: Medication Compliance Phone Call----[1] 98 💬
180Other: Oral Nitric Oxide testing[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 98 💬
181Other: Saline----[8] 2, 6, 46, 97, 98, 256, 274, 301 💬
182Other: Symptom Survey----[1] 98 💬
183Other: Xanthan Gum[1] Xanthan gum[1] Xanthan gum 💬 --[1] 98 💬
184Potassium[1] Potassium[1] Potassium 💬 --[17] 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
185Propofol[1] Propofol[1] Propofol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[10] 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
186QAX576----[4] 51, 85, 96, 98 💬
187Radiation: Computerized Tomography scan----[1] 98 💬
188Radiation: Esophageal Barium Xray[1] Barium---[1] 98 💬
189Radiation: Planar Images----[1] 98 💬
190Radiation: Single Photon Emission Computed Tomography scans----[1] 98 💬
191Reslizumab[1] Reslizumab[1] Reslizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[2] 44, 98 💬
192RPC4046----[1] 98 💬
193SB-240563----[3] 44, 45, 98 💬
194SCH55700----[1] 98 💬
195Sevoflurane[1] Sevoflurane[1] Sevoflurane 💬 --[8] 6, 21, 22, 34, 70, 98, 225, 296 💬
196Sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[46] 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
197Solrikitug[1] Solrikitug[1] Solrikitug 💬 [1] CRLF2 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
198Solrikitug High Dose[1] Solrikitug[1] Solrikitug 💬 [1] CRLF2 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
199Solrikitug Low Dose[1] Solrikitug[1] Solrikitug 💬 [1] CRLF2 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
200Solrikitug Mid Dose[1] Solrikitug[1] Solrikitug 💬 [1] CRLF2 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
201Steroid and Proton Pump Inhibitor Therapy----[1] 98 💬
202Stool sampling----[2] 97, 98 💬
203Sucralfate[1] Sucralfate[1] Sucralfate 💬 --[1] 98 💬
204Swallowed fluticasone[1] Fluticasone[1] Fluticasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
205Technetium Tc 99M----[1] 98 💬
206Tezepelumab[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[3] 44, 45, 98 💬
207Tezepelumab APFS[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
208Tezepelumab via APFS[1] Tezepelumab[1] Tezepelumab 💬 [1] TSLP 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 98 💬
209Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms[1] Lansoprazole[1] Lansoprazole 💬 [2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
210Unstimulated saliva sampling----[1] 98 💬
211Upadacitinib[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬
[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[12] 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
212Upadacitinib 30mg Dose[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬
[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 98 💬
213Urine sampling----[1] 98 💬
214Viaskin Milk 500 mcg----[1] 98 💬
215Viscous/swallowed budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
216Vitamin D[1] Vitamin D---[26] 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
217Vonoprazan[1] Vonoprazan[1] Vonoprazan 💬 [2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[3] 63, 97, 98 💬
218Wheat[1] Wheat[1] Wheat 💬 --[5] 6, 53, 97, 98, 266 💬
219Xanthan gum[1] Xanthan gum[1] Xanthan gum 💬 --[1] 98 💬
220Xylose[1] Xylose[1] Xylose 💬 --[1] 98 💬
221Zofran - no intubation----[1] 98 💬